-
Forward Look
A Burning Question for SmokersIs the considerable risk-reduction benefit of CT screening worth the potential downsides?
by Sue Rochman
-
Forward Look
Avastin’s FateDebate goes on as FDA revokes drug's use for breast cancer.
by Alanna Kennedy-Gorman
-
Survivor Profile
When Cancer Meets Inner DriveDiagnosed at 28, Rochelle Shoretz has stayed true to her big dreams and to her goal of helping other young women with breast cancer.
by Yvonne Lee
-
Staying the CoursePatients are increasingly skipping treatment breaks and opting for ongoing treatment known as maintenance therapy to try to keep some types of cancer at bay.
by Melissa Weber
-
The Birth of a Targeted TherapyA serendiptious discovery more than 50 years ago heralded a new age of cancer treatment.
by Jocelyn Selim
-
The Wait for a MatchMany patients in urgent need of bone marrow or stem cell transplants are facing uncertainty.
by Karen Patterson
-
Yesterday & Today
A King’s LegacyMore than a quarter century after Yul Brynner's death from lung cancer, treatment advances offer some patients new options, but the cancer continues to claim more lives than any other. And the actor's haunting anti-smoking message lives on.
by Sue Rochman
-
Global Report
Stark Realities in ZambiaAn American cancer survivor's visit to a Southern African nation reveals how doctors are adapting cancer care to meet an overwhelming need.
by Cynthia Ryan
Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.
by Marci A. Landsmann
Understanding Stress and CancerA symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.
by Eric Fitzsimmons
Exploring Amino Acids’ Impact on Tumor GrowthResearchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
by Thomas Celona
Study Shows Minority Participation in Clinical Trials May Be DecliningResearcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
-
Using Lymphocytes to Attack TumorsSooner rather than later may be the best strategy for using an experimental treatment for advanced melanoma.
-
Closing Disparities Through Genetic TestingOlufunmilayo Olopade seeks widespread use of testing to encourage prevention and early detection of deadly cancers.
Learning Medicare’s ABCDs
